TABLE 2

Neurophysiological and sensory variables in patients and healthy control subjects at baseline

Healthy control subjectsC-peptidePlacebo
n152620
MCV (m/s)53.5 ± 1.13*44.9 ± 0.7946.7 ± 0.71
CMAP (mV)8.38 ± 0.556.96 ± 0.507.60 ± 0.41
SCV (m/s)54.2 ± 1.2450.5 ± 0.8951.4 ± 1.12
SNAP (μV)19.2 ± 2.3716.3 ± 1.8115.8 ± 1.92
Cold threshold2.03 ± 0.173.4 ± 0.552.1 ± 0.17
Heat threshold6.46 ± 0.518.0 ± 0.437.0 ± 0.47
Vibration threshold0.52 ± 0.100.63 ± 0.070.48 ± 0.07
  • Data are means ± SE for both legs.

  • *

    * P < 0.001;

  • P < 0.05 for difference between diabetic patients and healthy control subjects. None of the variables differed significantly between the two patient groups.